Ticker ATHX – Athersys – sales, description, marketcap – Tickerday.com

ATHX

Athersys

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 396.78M; Volume: 223.64K; AvgVol 3m: 2.31M; Beta: -1.75;

Cost estimate:

P/E: –; EPS: -0.33; EPS growth quarter/prev quarter: -48.80%;

EPS growth this year: -65.40%; EPS growth past 5 years: -0.50%;

EPS ttm: -0.33;

P/S: 39943.80; P/B: 5.74; P/Cashflow: 4.95; P/FCF: ;

Sales: 10.00K; Sales growth quarter/prev quarter: -97.70%; Sales growth past 5 years: 28.30%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -104.30%; ROE – return on equity: -167.70%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 10.20%; Insider Transactions:0.43%;

Institutional Ownership: 29.20%; Institutional Transactions: 62.87%;

Data update: 07/10/2020.